Avidity Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2018
Revenue	18.76	10.9	9.56	9.22	9.33	Upgrade
Revenue Growth (YoY)	72.11%	13.98%	3.64%	-1.09%	37.41%	Upgrade
Cost of Revenue	559.16	303.59	190.97	150.4	101.18	Upgrade
Gross Profit	-540.4	-292.7	-181.41	-141.18	-91.86	Upgrade
Selling, General & Admin	205.54	86.24	54.19	37.73	26.2	Upgrade
Operating Expenses	205.54	86.24	54.19	37.73	26.2	Upgrade
Operating Income	-745.94	-378.94	-235.6	-178.91	-118.05	Upgrade
Interest & Investment Income	63.26	56.88	23.97	4.98	0.1	Upgrade
Other Non Operating Income (Expenses)	-1.94	-0.25	-0.59	-0.06	-0.06	Upgrade
Pretax Income	-684.63	-322.3	-212.22	-174	-118.01	Upgrade
Net Income	-684.63	-322.3	-212.22	-174	-118.01	Upgrade
Net Income to Common	-684.63	-322.3	-212.22	-174	-118.01	Upgrade
Shares Outstanding (Basic)	138	112	73	52	41	Upgrade
Shares Outstanding (Diluted)	138	112	73	52	41	Upgrade
Shares Change (YoY)	23.42%	52.83%	39.97%	25.91%	91.24%	Upgrade
EPS (Basic)	-4.97	-2.89	-2.91	-3.34	-2.85	Upgrade
EPS (Diluted)	-4.97	-2.89	-2.91	-3.34	-2.85	Upgrade
Free Cash Flow	-663.76	-307.94	-123.29	-139.09	-98.55	Upgrade
Free Cash Flow Per Share	-4.82	-2.76	-1.69	-2.67	-2.38	Upgrade
Operating Margin	-3977.30%	-3477.43%	-2464.41%	-1939.65%	-1265.83%	Upgrade
Profit Margin	-3650.39%	-2957.71%	-2219.87%	-1886.33%	-1265.38%	Upgrade
Free Cash Flow Margin	-3539.11%	-2825.88%	-1289.66%	-1507.92%	-1056.76%	Upgrade
EBITDA	-741.79	-376.16	-233.5	-177.53	-117.41	Upgrade
D&A For EBITDA	4.15	2.78	2.1	1.39	0.64	Upgrade
EBIT	-745.94	-378.94	-235.6	-178.91	-118.05	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.